Alternative Procedures for Reducing Allogeneic Blood Transfusion in Elective Orthopedic Surgery

HSS Journal

Volumn 6, Issue 2, 2010, Pages 190-198

  Kleinert, Kathrin ^a   Theusinger, Oliver M ^b   Nuernberg, Johannes ^b   Werner, Clément M L ^a,b  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

allogeneic blood transfusion; autologous blood transfusion; blood loss; elective orthopedic surgery; EPO; fibrin sealant; hemodilution; iv iron; platelet gel; predonation

Indexed keywords

EID: 77956009922     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-009-9151-6     Document Type: Article

References (103)

1. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W, An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus. Med. 2006; 16(1): 31-39.
2. Andersson I, Tylman M, Bengtson JP, Bengtsson A, Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can. J. Anaesth. 2001; 48(3): 251-255.
3. Anonym, Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study Group. Lancet. 1993; 341(8855): 1227-1232.
4. Beck-Schimmer B, Romero B, Booy C, Joch H, Hallers U, Pasch T, Spahn DR, Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. Eur. J. Anaesthesiol. 2004; 21(1): 46-52.
5. Bennett J, Haynes S, Torella F, Grainger H, McCollum C, Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion. 2006; 46(7): 1097-1103.
6. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, van der Linden P, Perioperative anaemia management: consensus statement on the role of intravenous iron. Br. J. Anaesth. 2008; 100(5): 599-604.
7. Blumberg N, Heal JM, Effects of transfusion on immune function. Cancer recurrence and infection. Arch. Pathol. Lab. Med. 1994; 118(4): 371-379.
8. Borghi B, Casati A, Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur. J. Anaesthesiol. 2000; 17(7): 411-417.
9. Bryson GL, Laupacis A, Wells GA, Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth. Analg. 1998; 86(1): 9-15.
10. Chassot PG, Delabays A, Spahn DR, Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br. J. Anaesth. 2007; 99(3): 316-328.
11. Chassot PG, Delabays A, Spahn DR, Perioperative use of anti-platelet drugs. Best Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 241-256.
12. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J, Update on adverse drug events associated with parenteral iron. Nephrol. Dial. Transplant. 2006; 21(2): 378-382.
13. Chun TY, Martin S, Lepor H, Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology. 1997; 50(5): 727-732.
14. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS, Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am. Surg. 2002; 68(7): 566-572.
15. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J. Am. Soc. Nephrol. 2007; 18(3): 975-984.
16. Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M, Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion. 2006; 46(7): 1112-1119.
17. Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M, Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch. Orthop. Trauma. Surg. 2005; 125(5): 342-347.
18. Cuenca J, Garcia-Erce JA, Munoz M, Izuel M, Martinez AA, Herrera A, Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion. 2004; 44(10): 1447-1452.
19. Dahl NV, Henry DH, Coyne DW, Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role? Semin. Dial. 2008; 21(3): 210-211.
20. Dai B, Wang L, Djaiani G, Mazer CD. Continuous and discontinuous cell-washing autotransfusion systems. J. Cardiothorac. Vasc. Anesth. 2004; 18(2): 210-217.
21. Diez-Lobo AI, Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfusion Alternatives in Transfusion Medicine. 2007; 9(2): 114-119.
22. Dodd RY, The risk of transfusion-transmitted infection. N. Engl. J. Med. 1992; 327(6): 419-421.
23. Dodd RY, Current risk for transfusion transmitted infections. Curr. Opin. Hematol. 2007; 14(6): 671-676.
24. Duffy G, Neal KR, Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus. Med. 1996; 6(4): 325-328.
25. Earley AS, Gracias VH, Haut E, Sicoutris CP, Wiebe DJ, Reilly PM, Schwab CW, Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. J. Trauma. 2006; 61(1): 1-5. discussion 5-7.
26. Eroglu A, Uzunlar H, Erciyes N, Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J. Clin. Anesth. 2005; 17(6): 420-425.
27. Erslev AJ, Erythropoietin. N. Engl. J. Med. 1991; 324(19): 1339-1344.
28. Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A, Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta. Anaesthesiol. Scand. 2006; 50(5): 593-599.
29. Ferraris VA et al, Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann. Thorac. Surg. 2007; 83(5 Suppl): S27-S86.
30. Fopp M, Sicherheit der Bluttransfusion heute. Schweiz. Med. Forum 2006; 6: 139-144.
31. Franchini M, Targher G, Montagnana M, Lippi G, Iron and thrombosis. Ann. Hematol. 2008; 87(3): 167-173.
32. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P, Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy-a porcine model. Br. J. Anaesth. 2006; 97(4): 460-467.
33. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, Haas T, Innerhofer P, Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br. J. Anaesth. 2005; 95(2): 172-177.
34. Ganter MT, Hofer CK, Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analg. 2008; 106(5): 1366-1375.
35. Goldman M, Remy-Prince S, Trepanier A, Decary F, Autologous donation error rates in Canada. Transfusion. 1997; 37(5): 523-527.
36. Goodnough LT, Monk TG, Despotis GJ, Merkel K, A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox. Sang. 1999; 77(1): 11-16.
37. Goodnough LT, Shander A, Brecher ME, Transfusion medicine: looking to the future. Lancet. 2003; 361(9352): 161-169.
38. Goodnough LT, Skikne B, Brugnara C, Erythropoietin, iron, and erythropoiesis. Blood. 2000; 96(3): 823-833.
39. Habler O, Meier J, Pape A, Kertscho H, Zwissler B, [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits]. Orthopade. 2007; 36(8): 763-776. quiz 777-778.
40. Habler O, Messmer K, [Methods for reduction of homologous blood transfusions in operative medicine]. Anaesthesist. 1997; 46(11): 915-926.
41. Habler O et al, Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. Int. J. Oral Maxillofac. Surg. 2004; 33(5): 467-475.
42. Healy JC, Frankforter SA, Graves BK, Reddy RL, Beck JR, Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis. Arch. Pathol. Lab. Med. 1994; 118(4): 465-470.
43. Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN, A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion. 1992; 32(8): 742-746.
44. Henry DA, Carless PA, Moxey AJ, O'Connell D, Forgie MA, Wells PS, Fergusson D, Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst. Rev. 2002; (2): CD003602.
45. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP, Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J. Trauma. 2003; 54(5): 908-914.
46. Ishii Y, Matsuda Y, Effect of the timing of tourniquet release on perioperative blood loss associated with cementless total knee arthroplasty: a prospective randomized study. J. Arthroplasty. 2005; 20(8): 977-983.
47. Jelkmann W, Developments in the therapeutic use of erythropoiesis stimulating agents. Br. J. Haematol. 2008; 141(3): 287-297.
48. Juelsgaard P, Larsen UT, Sorensen JV, Madsen F, Soballe K, Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg. Anesth. Pain Med. 2001; 26(2): 105-110.
49. Karger R, Kretschmer V, Modern concepts of autologous haemotherapy. Transfus. Apher. Sci. 2005; 32(2): 185-196.
50. Kjaergard HK, Fairbrother JE, Controlled clinical studies of fibrin sealant in cardiothoracic surgery-a review. Eur. J. Cardiothorac. Surg. 1996; 10(9): 727-733.
51. Klein HG, Spahn DR, Carson JL, Red blood cell transfusion in clinical practice. Lancet. 2007; 370(9585): 415-426.
52. Kopko PM, Holland PV, Transfusion-related acute lung injury. Br. J. Haematol. 1999; 105(2): 322-329.
53. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C, A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am. J. Gastroenterol. 2008; 103(5): 1182-1192.
54. Larkin M, Value of preoperative autologous blood donation questioned. The Lancet. 2002; 360: 696.
55. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H, The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J. Bone Joint Surg. Am. 1999; 81(11): 1580-1588.
56. Lincoln JA, Lefkowitz DL, Cain T, Castro A, Mills KC, Lefkowitz SS, Moguilevsky N, Bollen A, Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect. Immun. 1995; 63(8): 3042-3047.
57. Luddington RJ, Thrombelastography/thromboelastometry. Clin. Lab. Haematol. 2005; 27(2): 81-90.
58. Madjdpour C, Spahn DR, Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br. J. Anaesth. 2005; 95(1): 33-42.
59. Mankad PS, Codispoti M, The role of fibrin sealants in hemostasis. Am. J. Surg. 2001; 182(2 Suppl): 21S-28S.
60. Marik PE, Corwin HL, Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit. Care Med. 2008; 36(9): 2667-2674.
61. Matot I, Scheinin O, Jurim O, Eid A, Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology. 2002; 97(4): 794-800.
62. McShane AJ, Martin JL, Preoxygenation and pulse oximetry may delay detection of esophageal intubation. J. Natl. Med. Assoc. 1987; 79(9): 991-992.
63. Messmer K, Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management. Semin. Hematol. 1996; 33(2 Suppl 2): 78-80.
64. Monk TG, Goodnough LT, Brecher ME, Colberg JW, Andriole GL, Catalona WJ, A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology. 1999; 91(1): 24-33.
65. Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P, Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion. 2007; 47(3): 379-384.
66. Moonen AF, Neal TD, Pilot P, Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature. Injury. 37(Suppl 5): S11-S16.
67. Morgan GE Jr, Mikhail MS, Murray MJ, Larson P Jr (eds), Geriatric anesthesia. In: Clinical Anesthesiology. New York: McGraw-Hill; 2002: 875-881.
68. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF, Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 1987; 237(4820): 1333-1336.
69. Nelson CL, Bowen WS, Total hip arthroplasty in Jehovah's Witnesses without blood transfusion. J. Bone Joint Surg. Am. 1986; 68(3): 350-353.
70. Niemi TT, Pitkanen M, Syrjala M, Rosenberg PH, Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta. Anaesthesiol. Scand. 2000; 44(4): 457-464.
71. Pape A, Habler O, Alternatives to allogeneic blood transfusions. Best. Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 221-239.
72. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF, Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 1989; 109(1): 429-440.
73. Reize P, Wulker N, [Foreign blood saving measures in orthopedic surgery]. Orthopade. 2007; 36(6): 537-543.
74. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL, Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4): 459-469.
75. Sans T, Bofill C, JJ, Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery. Transfusion. 1996; 36: 822-826.
76. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A, Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet. 1996; 347(8997): 289-292.
77. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E, Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion. 2004; 44(5): 632-644.
78. Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR, Estimating the cost of blood: past, present, and future directions. Best Pract. Res. Clin. Anaesthesiol. 2007; 21(2): 271-289.
79. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA, Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth. Analg. 1999; 88(2): 312-319.
80. Slappendel R, Weber EW, Benraad B, Dirksen R, Bugter ML, Does ibuprofen increase perioperative blood loss during hip arthroplasty? Eur. J. Anaesthesiol. 2002; 19(11): 829-831.
81. Spahn DR, Casutt M, Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000; 93(1): 242-255.
82. Spahn DR, Chassot PG, Zaugg M, Pragmatic treatment versus elaborative but incomplete testing: a Hobson's choice? Anesthesiology. 2007; 107(4): 526-529.
83. Spahn DR, Howell SJ, Delabays A, Chassot PG, Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br. J. Anaesth. 2006; 96(6): 675-677.
84. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM, [Bedside thrombelastography. Cost reduction in cardiac surgery]. Anaesthesist. 2007; 56(8): 765-771.
85. Spence RK, Emerging trends in surgical blood transfusion. Semin. Hematol. 1997; 34(3 Suppl 2): 48-53.
86. Tartter PI, Quintero S, Barron DM, Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am. J. Surg. 1986; 152(5): 479-482.
87. Tenholder M, Cushner FD, Intraoperative blood management in joint replacement surgery. Orthopedics. 2004; 27(6 Suppl): s663-s668.
88. Terada N, Arai Y, Matsuta Y, Maekawa S, Okubo K, Ogura K, Matsuda N, Yonei A, Acute normovolemic hemodilution for radical prostatectomy: can it replace preoperative autologous blood transfusion? 2001; Int. J. Urol. 2001; 8(4): 149-152.
89. Theusinger OM, Leyvraz PF, Schanz U, Seifert B, Spahn DR, Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology. 2007; 107(6): 923-927.
90. Triulzi DJ, Blumberg N, Heal JM, Association of transfusion with postoperative bacterial infection. Crit. Rev. Clin. Lab. Sci. 1990; 28(2): 95-107.
91. Vamvakas EC, Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995; 35(9): 760-768.
92. Vamvakas EC, Moore SB, Cabanela M, Blood transfusion and septic complications after hip replacement surgery. Transfusion. 1995; 35(2): 150-156.
93. Vamvakas EC, Pineda AA, Autologous transfusion and other approaches to reduce allogeneic blood exposure. Baillieres Best Pract. Res. Clin. Haematol. 2000; 13(4): 533-547.
94. Varney SJ, Guest JF, The annual cost of blood transfusions in the UK. Transfus. Med. 2003; 13(4): 205-218.
95. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD, Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J. Bone. Joint. Surg. Am. 2001; 83-A(10): 1503-1505.
96. Weber EW, Slappendel R, Durieux ME, Dirksen R, van der Heide H, Spruit M, COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur. J. Anaesthesiol. 2003; 20(12): 963-966.
97. Weiskopf RB, Aminoff MJ, Hopf HW, Feiner J, Viele MK, Watson JJ, Ho R, Songster C, Toy P, Acute isovolemic anemia does not impair peripheral or central nerve conduction. Anesthesiology. 2003; 99(3): 546-551.
98. Weiss G, Goodnough LT, Anemia of chronic disease. N. Engl. J. Med. 2005; 352(10): 1011-1023.
99. Winkler M et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth. Analg. 2000; 91(4): 978-984.
100. Wong JC, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN, Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann. Surg. 2002; 235(1): 145-151.
101. Woolson ST, Pottorff G, Use of preoperatively deposited autologous blood for total knee replacement. Orthopedics. 1993; 16(2): 137-141. discussion 141-2.
102. Woolson ST, Watt JM, Use of autologous blood in total hip replacement. A comprehensive program. J. Bone Joint Surg. Am. 1991; 73(1): 76-80.
103. Wrotniak M, Bielecki T, Gazdzik TS, Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop. Traumatol. Rehabil. 2007; 9(3): 227-238.